Loading...
Keywords
Last Name
Institution

Connection

Search Results to Susana Chavez-Bueno

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Chavez-Bueno, Susana

PropertyValue
research overview Dr. Chavez-Bueno’s current research work focuses on the pathogenesis of E. coli sepsis in newborns. Her overall research goal is to identify novel virulence factors relevant to the pathogen’s ability to traverse the gut and invade the bloodstream causing neonatal sepsis. Her studies utilize in vitro and in animal models designed to characterize the bacterial components that determine invasion and trafficking across intestinal epithelium and interact with gut specific immune regulators as potential therapeutic targets to decrease life-threatening neonatal E. coli disease. Dr. Chavez-Bueno is an elected member of the Society for Pediatric Research and currently serves on the Research Committee for the Infectious Diseases Society of America.

One or more keywords matched the following items that are connected to Chavez-Bueno, Susana

Item TypeName
Concept Drug Therapy, Combination
Concept Treatment Outcome
Academic Article Treatment of experimental chronic pulmonary mycoplasmosis.
Academic Article Therapist focus on ambivalence and commitment: a longitudinal analysis of Motivational Interviewing treatment ingredients.
Grant A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate a Single Intramuscular Dose of Motavizumab (MEDI-524), a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), for the Outpatient Treatment of Children with RSV Illness
Grant A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate a Single Intravenous Dose of Motavizumab (MEDI-524), a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), for the Treatment of Children Hospitalized with RSV Illness
Grant An Open Label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir (Tamiflu®) in the Treatment of Children 1 to 12 years of age with Influenza Infection
Academic Article Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
Academic Article Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumonia.
Academic Article Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia.
Academic Article Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model.
Academic Article Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.
Academic Article Respiratory syncytial virus bronchiolitis : current and future strategies for treatment and prophylaxis.
Academic Article Bacterial meningitis in children.
Academic Article [Asthma and respiratory syncytial virus. New opportunities for therapeutic intervention].

Search Criteria
  • Experimental
  • Therapeutics